XML 56 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

REVENUE (Tables) | 12 Months Ended
--- | ---
Oct. 31, 2025
Revenue from Contract with Customer [Abstract] |
Disaggregation of Revenue | The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
| Life Sciences and Diagnostics Markets |  | Agilent CrossLab |  | Applied Markets |  | Total
| (in millions)
Year Ended October 31, 2025: |  |  |  |  |  |  |
Americas | $ | 1,337 |  |  | $ | 1,095 |  |  | $ | 374 |  |  | $ | 2,806 |
Europe | 786 |  |  | 811 |  |  | 326 |  |  | 1,923 |
Asia Pacific | 603 |  |  | 1,002 |  |  | 614 |  |  | 2,219 |
Total | $ | 2,726 |  |  | $ | 2,908 |  |  | $ | 1,314 |  |  | $ | 6,948 |
Year Ended October 31, 2024: |  |  |  |  |  |  |
Americas | $ | 1,157 |  |  | $ | 1,048 |  |  | $ | 368 |  |  | $ | 2,573 |
Europe | 723 |  |  | 741 |  |  | 306 |  |  | 1,770 |
Asia Pacific | 586 |  |  | 958 |  |  | 623 |  |  | 2,167 |
Total | $ | 2,466 |  |  | $ | 2,747 |  |  | $ | 1,297 |  |  | $ | 6,510 |
Year Ended October 31, 2023: |  |  |  |  |  |  |
Americas | $ | 1,333 |  |  | $ | 1,003 |  |  | $ | 396 |  |  | $ | 2,732 |
Europe | 729 |  |  | 701 |  |  | 324 |  |  | 1,754 |
Asia Pacific | 718 |  |  | 952 |  |  | 677 |  |  | 2,347 |
Total | $ | 2,780 |  |  | $ | 2,656 |  |  | $ | 1,397 |  |  | $ | 6,833 |
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
|  | Years Ended October 31,
|  | 2025 |  | 2024 |  | 2023
| (in millions)
Revenue by End Markets |  |  |  |  |  |
Pharmaceutical and Biopharmaceutical |  | $ | 2,507 |  |  | $ | 2,242 |  |  | $ | 2,433 |
Chemicals and Advanced Materials |  | 1,561 |  |  | 1,495 |  |  | 1,543 |
Diagnostics and Clinical |  | 1,029 |  |  | 964 |  |  | 966 |
Food |  | 637 |  |  | 592 |  |  | 628 |
Academia and Government |  | 540 |  |  | 567 |  |  | 601 |
Environmental and Forensics |  | 674 |  |  | 650 |  |  | 662 |
Total |  | $ | 6,948 |  |  | $ | 6,510 |  |  | $ | 6,833 |
Revenue by Type |  |  |  |  |  |
Instrumentation |  | $ | 2,427 |  |  | $ | 2,354 |  |  | $ | 2,742 |
Non-instrumentation and other |  | 4,521 |  |  | 4,156 |  |  | 4,091 |
Total |  | $ | 6,948 |  |  | $ | 6,510 |  |  | $ | 6,833 |
Contract with Customer, Asset and Liability | The following table provides information about contract liabilities (deferred revenue) and the significant changes in the balances during the years ended October 31, 2024 and 2025:
|  | Contract Liabilities
|  | (in millions)
Ending balance as of October 31, 2023 |  | $ | 616 |
Net revenue deferred in the period |  | 469 |
Revenue recognized that was included in the contract liability balance at the beginning of the period |  | (448) |
Change in deferrals from customer cash advances, net of revenue recognized |  | (9) |
Contract liabilities acquired in business combinations |  | 70 |
Currency translation and other adjustments |  | 3 |
Ending balance as of October 31, 2024 |  | $ | 701 |
Net revenue deferred in the period |  | 564 |
Revenue recognized that was included in the contract liability balance at the beginning of the period |  | (476) |
Change in deferrals from customer cash advances, net of revenue recognized |  | 7 |
Currency translation and other adjustments |  | 7 |
Ending balance as of October 31, 2025 |  | $ | 803 |

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration